Open Access

Effects of TONS504‑photodynamic therapy on mouse mammary tumor cells

  • Authors:
    • Tomohiro Osaki
    • Isao Sakata
    • Yoshihiro Uto
    • Masamichi Yamashita
    • Yusuke Murahata
    • Kazuo Azuma
    • Takeshi Tsuka
    • Norihiko Ito
    • Tomohiro Imagawa
    • Yoshiharu Okamoto
  • View Affiliations

  • Published online on: June 4, 2018     https://doi.org/10.3892/ol.2018.8887
  • Pages: 2078-2084
  • Copyright: © Osaki et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, TONS504 (C51H58N8O5I2; molecular weight, 1,116.9), a novel cationic hydrophilic photosensitizer, was synthesized from protoporphyrin IX dimethyl ester through a five‑step process according to a patented method for use in photodynamic therapy (PDT). The subcellular localization of TONS504 and the cytotoxic effects of TONS504‑mediated PDT in the mouse mammary tumor EMT6 cell line were investigated. TONS504 was localized primarily in the lysosomes and partially in the mitochondria. The cytotoxic effects of TONS504‑mediated PDT in the mouse mammary tumor EMT6 cell line were investigated using a WST8 assay and an Oxidative Stress kit. The cell viability values following treatment with 10 µg/ml TONS504 at light energies of 0, 1, 5 and 10 J/cm2 were 92.5, 101.8, 27.7 and 1.8%, respectively. The percentages of reactive oxygen species (ROS)(+) cells following the same treatment were 8.6, 8.5, 29.2 and 70.1%, respectively, whereas the percentages of apoptotic cells were 7.1, 5.6, 24.8 and 48.7%, respectively. The percentages of ROS(+) and apoptotic cells in the group subjected to TONS504‑mediated PDT increased in a manner dependent on the TONS504 concentration and light energy. Further studies are required to evaluate the in vivo pharmacokinetics, tissue distribution and photodynamic effects of TONS504.

Introduction

Mammary tumors remain the most common cancer and one of the most fatal diseases in females globally, accounting for 14% of the total cancer mortalities in 2018 (13). With improved breast screening procedures, mammary tumors can be diagnosed at an early stage. Consequently, less extensive treatment may be required (3).

Photodynamic therapy (PDT) is a minimally invasive cancer treatment. The key agent used in PDT is a photosensitizer, which is a compound that is excited by light and is converted to a triplet-excited state (4,5). Osaki et al, Takahashi et al and Sakata et al developed three novel photosensitizers, TONS501Na (6), TONS501 (7), and TONS504 (68). TONS501Na (C37H38N4Na2O7; molecular weight, 696.8) is a hydrophilic and anionic porphyrin salt, and is a chlorin derivative that can be synthesized from the protoporphyrin IX dimethyl ester via a four-step process (8). In a previous study, TONS501Na-mediated PDT induced the death of mouse mammary tumor EMT6 cells in a concentration-dependent manner; however, dark cytotoxicity was also observed with TONS501Na (6). Therefore, photosensitizers that are ideal for PDT against tumors are required.

TONS504 (Fig. 1) is a novel cationic hydrophilic photosensitizer (C51H58N8O5I2; molecular weight, 1,116.9) that is synthesized from protoporphyrin IX dimethyl ester via a five-step process (9,10). PDT mediated by TONS504 ointment was reported to produce potent antitumor effects in mouse skin papilloma in an in vivo study (7).

To the best of our knowledge, the effectiveness of TONS504-mediated PDT has not been previously reported in an in vitro study. In the present study, the subcellular localization of TONS504 and the cytotoxic effects of TONS504-mediated PDT in EMT6 cells were investigated.

Materials and methods

Cell line and culture conditions

Mouse mammary tumor EMT6 cells were supplied by Dr Shinichiro Masunaga of Kyoto University (Kyoto, Japan). The cells were maintained as an adherent monolayer culture in RPMI-1640 medium (Invitrogen; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Nichirei Biosciences Inc., Tokyo, Japan) and antibiotics (5 mg/ml penicillin, 5 mg/ml streptomycin and 10 mg/ml neomycin; Invitrogen; Thermo Fisher Scientific, Inc.) in an atmosphere containing 5% CO2 at 37°C. All subsequent incubations were also performed at 37°C.

The cells were harvested from near-confluent cultures by brief exposure to a solution containing 0.25% trypsin and 1 mmol/l ethylenediaminetetraacetic acid (tetrasodium salt) solution with phenol red (Invitrogen; Thermo Fisher Scientific, Inc.). Trypsinization was stopped using RPMI-1640 containing 10% FBS. The cells were concentrated via centrifugation at 300 × g for 5 min at room temperature and resuspended in RPMI-1640. The cell suspension was mixed at 1:1 with 0.4% Trypan blue at room temperature and immediately loaded into the counting chamber slide (Watson Bio Lab; Fukae-Kasei Co., Ltd., Kobe, Japan). Within 5 min, the Trypan blue exclusion assay was performed to assess cell viability using an inverted microscope (Nikon Eclipse TS100; Nikon Corporation, Tokyo, Japan) at a magnification of ×100.

Chemicals

MitoTracker Green FM and LysoTracker Yellow HCK-123 were obtained from Thermo Fisher Scientific Inc. Cell Counting Kit-8 and the PromoKine Apoptotic/Necrotic Cells Detection kit were purchased from Dojindo Molecular Technologies, Inc., (Kumamoto, Japan) and PromoCell GmbH (Heidelberg, Germany), respectively. The Muse® Oxidative Stress kit and the Muse Annexin V and Dead Cell assay kit were purchased from EMD Millipore (Billerica, MA, USA).

Subcellular localization of TONS504

The intracellular distribution of TONS504 was monitored using an Olympus Fluoview FV1000 (Olympus Corporation, Tokyo, Japan) confocal laser scanning microscope (CLSM). The EMT6 cells were seeded in 8-well cell culture slides (SPL Life Sciences, Pocheon, Korea) and incubated in RPMI-1640 medium for 24 h at 37°C. Following this, the cells were incubated with TONS504 at a final concentration of 30 µg/ml for 4 h, followed by co-incubation with 100 nM MitoTracker Green FM and 50 nM LysoTracker Yellow HCK-123 for an additional 30 min in the culture medium prior to a CLSM being used. The fluorescence of TONS504 was detected at an excitation wavelength of 543 nm using a helium-neon (G) laser and a 560-nm long-pass filter. The fluorescent signals of MitoTracker Green FM and LysoTracker Yellow HCK-123 were detected by excitation at 488 nm using an argon laser, a 560 nm dichroic mirror and a 505–525 nm band-pass barrier filter.

Uptake kinetics of TONS504

The EMT6 cells were seeded at 1–2×104 cells/well in 96-well plates (Corning Incorporated, Corning, NY, USA) in RPMI-1640 medium supplemented with 10% FBS and incubated for 24 h in an atmosphere of 5% CO2 at 37°C. Next, the cells were incubated with TONS504 at a final concentration of 30 µg/ml for 12 h at 37°C. Images were automatically captured every 1 h for 12 h using the IncuCyte® S3 system (Essen BioScience, Ann Arbor, MI, USA) in phase-contrast and fluorescence modes. Phase contrast and red-phase images were obtained from the system. The total fluorescence intensity of objects in an image was determined by object counting using the image analysis software IncuCyte (IncuCyte® S3 Software; Essen Bioscience, Ann Arbor, MI, USA).

Evaluation of the cytotoxic effects of TONS504 and light in EMT6 cells

EMT6 cells were seeded at 1–2×104 cells/well in 96-well plates (Corning Incorporated) and incubated for 24 h. The cells were then incubated with various concentrations of TONS504 (0, 1, 3, 10, 30 or 100 µg/ml) for 24 h at 37°C. Following replacing with fresh RPMI-1640 medium supplemented with 10% FBS, the cells were irradiated by a semiconductor laser at a wavelength of 677 nm. PDT was performed at 11 mW/cm2 in cells exposed to TONS504 (0, 1, 3, 10, 30 or 100 µg/ml), using four light doses (0, 1, 5 or 10 J/cm2). The cells were then incubated for 24 h in the dark prior to assessing their viability using a WST8 assay (Cell Counting Kit-8; Dojindo Molecular Technologies, Inc.), according to the manufacturer's protocols. The cytotoxic effects of PDT were evaluated to calculate the appropriate concentration of TONS504 and light dose for the following experiment. The concentrations of TONS504 or light doses that were too low were ineffective; however, the concentrations of TONS504 or light doses that were too high were too effective. The optimal concentrations of TONS504 and light dose were 10 µg/ml and 5 J/cm2 respectively, which results in the best cytotoxic effect.

Kinetics experiment to assess apoptosis

EMT6 cells were seeded at 1–2×104 cells/well in 96-well plates (Corning Incorporated) and incubated for 24 h. The cells were then incubated with various concentrations of TONS504 (0, 1, 3, 10, 30 or 100 µg/ml) for 24 h at 37°C. Following replacing with fresh RPMI-1640 medium supplemented with 10% FBS, the cells were irradiated with 677-nm light emitted by a semiconductor laser. PDT was performed at 5 J/cm2, which was determined as optimal light dose by taking into consideration the results of the cytotoxicity effects of TONS504 and light on EMT6 cells. Then, the cells were stained with Annexin V-FITC immediately following PDT and incubated in an atmosphere containing 5% CO2 at 37°C for 24 h. Images were automatically captured every 1 h for 24 h in phase-contrast and fluorescence modes using the IncuCyte S3 system. Phase contrast and green-phase images were obtained from the system. The Total Green Object Integrated Intensity in an image was determined by object counting with IncuCyte® S3 Software according to the manufacturer's protocol. In the present study, object counting means the total sum of intensity of Annexin V Green fluorescence in the image.

Analysis of cell death

EMT6 cells were seeded at 4–5×104 cells/well in 35-mm petri dishes (Nalge Nunc International, Penfield, NY, USA) containing 2 ml RPMI-1640 medium supplemented with 10% FBS. Following 24 h of incubation, the cells were divided into the TONS504 groups (treated with 10 or 30 µg/ml TONS504) and the PDT groups (treated with 10 or 30 µg/ml TONS504 and then irradiated with a light dose of 1, 5 or 10 J/cm2). The concentration of used TONS504 was selected by taking into consideration the results of the cytotoxicity effects of TONS504 and light on EMT6 cells.

The cells were incubated with 10 or 30 µg/ml TONS504 for 24 h. Following washing with fresh media, the cells were irradiated with a laser light of wavelength 677 nm (11 mW/cm2; 0, 1, 5 or 10 J/cm2). Following 24 h of PDT, the cells were stained using the PromoKine Apoptotic/Necrotic Cells Detection kit, according to the manufacturer's protocols. To assess apoptosis and necrosis, the cells were stained with Annexin V-fluorescein isothiocyanate (FITC) and ethidium homodimer III (EthD-III) at 24 h after laser irradiation. Cell morphology was examined using a CLSM. The cells were analyzed by fluorescence microscopy using an FITC and Texas Red filter set.

Analysis of apoptosis and reactive oxygen species (ROS) generation

EMT6 cells were seeded at 4–5×104 cells/well in 35-mm petri dishes containing 2 ml culture medium. Following 24 h of incubation, the cells were divided into the following groups: Control (no treatment); laser (irradiated with a light dose of 10 J/cm2); TONS504 (treated with 10 or 30 µg/ml TONS504); and PDT (treated with 10 or 30 µg/ml TONS504, and then irradiated with a light dose of 1, 5 or 10 J/cm2). Following this, the cells were incubated with 10 or 30 µg/ml TONS504 for 24 h.

Apoptosis

Following the treatment with 10 or 30 µg/ml TONS504, the cells were washed with fresh media and irradiated with 677-nm light (1, 5 or 10 J/cm2). Apoptosis was assessed at 24 h after laser irradiation using the Muse Annexin V and Dead Cell Assay kit, according to the manufacturer's protocols. Annexin V was used to detect phosphatidylserine on the external membrane of apoptotic cells.

ROS assay

Following treatment with 10 or 30 µg/ml TONS504, the cells were washed with fresh media and irradiated with 677-nm light (1, 5 or 10 J/cm2). ROS generation was assessed at 24 h after laser irradiation using the Muse Oxidative Stress kit, according to the manufacturer's protocols. The kit was used to determine the percentages of cells that were ROS(−) (healthy cells) and ROS(+).

Statistical analysis

Data were analyzed using Sidak's multiple comparison test following two-way analysis of variance. P<0.05 was considered to indicate a statistically significant difference. Statistical analyses were performed using GraphPad Prism version 6 (GraphPad Software Inc., La Jolla, CA, USA). Results are presented as the mean ± standard deviation (n=3).

Results

Subcellular localization of TONS504

Confocal micrographs of EMT6 cells exposed to TONS504 and fluorescent molecular probes are depicted in Fig. 2. TONS504 was mainly localized in the lysosomes and partially localized in the mitochondria. No fluorescence was detected in the nuclei.

Uptake kinetics of TONS504

The uptake of TONS504 was investigated by studying its fluorescence emission using a live-cell analysis system. It was observed that fluorescence intensity increased slowly within 5 h, followed by a rapid increase up to 8 h post-incubation. Fluorescence reached a plateau at 10 h (Fig. 3).

TONS504- and light-induced cytotoxicities to EMT6 cells

The viability of EMT6 cells at 24 h post-PDT is illustrated in Fig. 4. Cell survival was dependent on TONS504 concentration or light dose, and was demonstrated to be markedly lower at high TONS504 concentrations compared with that at lower concentrations. No cytotoxicity was observed in cells treated with 0 J/cm2 of light. At 1 µg/ml TONS504, the cell viability in 1 J/cm2 of light was significantly lower compared with that in 0 J/cm2 of light (P=0.0046). Additionally, the cell viability in 5 J/cm2 of light was significantly lower compared with that in 1 J/cm2 of light (P<0.0001). Furthermore, the cell viability in 10 J/cm2 of light was significantly lower compared with that in 1 J/cm2 of light (P=0.029). At 3 µg/ml TONS504, the cell viability in 5 J/cm2 of light was significantly lower compared with that in 0 and 1 J/cm2 of light (both P<0.0001), and the cell viability in 10 J/cm2 of light was significantly lower compared with that in 0, 1 and 5 J/cm2 of light (all P<0.0001). At 10 µg/ml TONS504, the cell viability in 5 J/cm2 of light was significantly lower compared with that in 0 and 1 J/cm2 of light (both P<0.0001), and the cell viability in 10 J/cm2 of light was significantly lower compared with that in 0, 1 and 5 J/cm2 of light (all P<0.0001). At 30 µg/ml TONS504, the cell viability in 5 J/cm2 of light was significantly lower compared with that in 0 and 1 J/cm2 of light (both P<0.0001), and the cell viability in 10 J/cm2 of light was significantly lower compared with that in 0 and 1 J/cm2 of light (both P<0.0001). At 100 µg/ml TONS504, the cell viability in 1 J/cm2 of light was significantly lower compared with that in 0 J/cm2 of light (P<0.0001). The cell viability in 5 J/cm2 of light was significantly lower compared with that in 0 and 1 J/cm2 of light (both P<0.0001), and the cell viability in 10 J/cm2 of light was significantly lower compared with that in 0 and 1 J/cm2 of light (both P<0.0001).

The half maximal inhibitory concentration (IC50) was determined. It was determined that the IC50 values of TONS504 against EMT6 cells exposed to light doses of 5 and 10 J/cm2 were 5.9 and 1.9 µg/ml, respectively.

Kinetics experiment to assess apoptosis

Apoptosis induced by TONS504-mediated PDT was determined by Annexin V-FITC fluorescence using a live-cell analysis system. Apoptosis was dependent on the concentration of TONS504 (Fig. 5). At a low TONS504 concentration (<10 µg/ml), apoptosis occurred from ~10 h after PDT; however, treatment with 30 µg/ml TONS504 (middle dose) resulted in apoptosis induction at 1–3 h after PDT. Furthermore, when TONS504 was used at a high dose (100 µg/ml), apoptosis occurred immediately after PDT. The Total Green Object Integrated Intensity [green calibrated unit (GCU) × µm2/image] in 3 µg/ml TONS504 was significantly higher compared with that in 0 µg/ml TONS504 (P=0.0459). The GCU in 10 µg/ml TONS504 was significantly higher compared with that in 0, 1 and 3 µg/ml TONS504 (all P<0.0001). The GCU in 30 µg/ml TONS504 was significantly higher compared with that in 0, 1, 3 and 10 µg/ml TONS504 (all P<0.0001). The GCU in 100 µg/ml TONS504 was significantly higher compared with that in 0, 1, 3, 10 and 30 µg/ml TONS504 (all P<0.0001).

Analysis of cell death using a CLSM

The images of EMT6 cells stained with Annexin V-FITC and EthD-III at 24 h after PDT with 10 µg/ml TONS504 are depicted in Fig. 6. The cells subjected to PDT with 5 J/cm2 laser energy were stained with EthD-III, which indicated that they were necrotic (Fig. 6C). Furthermore, following PDT with 10 J/cm2 laser energy, different cells were positively stained with Annexin V or EthD-III, which indicated that they were apoptotic or necrotic (Fig. 6D).

The images of EMT6 cells stained with Annexin V-FITC and EthD-III at 24 h after PDT with 30 µg/ml TONS504 are depicted in Fig. 7. The cells that were subjected to PDT with 5 J/cm2 laser energy were stained with Annexin V and EthD-III, which indicated that they were in either in the late apoptosis or early necrosis stage (Fig. 7C); however, a decrease in the number of EMT6 cells was observed following PDT with 10 J/cm2 laser energy. In addition, different cells were stained with Annexin V or EthD-III, which indicated that the cells were apoptotic or necrotic (Fig. 7D).

ROS assay

The percentage of ROS(+) cells at 24 h after PDT is depicted in Fig. 8. For cells subjected to PDT with 5 J/cm2 laser energy, the percentage of ROS(+) cells following treatment with 30 µg/ml TONS504 was significantly higher compared with that of cells treated with 10 µg/ml TONS504 (P=0.001). By contrast, for cells subjected to PDT with 10 J/cm2 laser energy, the percentage of ROS(+) cells following treatment with 10 µg/ml TONS504 was significantly higher compared with that of cells treated with 30 µg/ml TONS504 (P=0.0048). The percentage of ROS(+) cells in the PDT group increased in a light- and dose-dependent manner for each TONS504 dose.

Analysis of apoptosis

At 24 h after PDT with 1, 5 or 10 J/cm2 laser energy, the apoptotic rates in groups treated with 10 µg/ml TONS504 were significantly higher compared with those in groups treated with 30 µg/ml TONS504 in the respective groups (all P<0.0001; Fig. 9). Furthermore, the percentage of apoptotic cells following PDT increased in a light- and dose-dependent manner for each TONS504 dose.

Discussion

In our previous study, CLSM analysis revealed that TONS501Na accumulates in the mitochondria and lysosomes (6). It was also reported that meso-tetra (hydroxyphenyl) chlorin and hypericin exhibit similar uptake kinetics, with a continuous increase in fluorescence within the first 20 h (11). In the present study, TONS504 accumulated primarily in the lysosomes. In addition, its uptake reached a plateau at 10 h. It was considered that TONS504, being cationic, may strongly interact with the cytomembrane, which possesses a negative charge, and enter the cells rapidly (12); therefore, TONS504 may partially move to the mitochondria following accumulation in the lysosomes.

In our previous study, TONS501Na-mediated PDT-induced cell death in EMT6 cells in a manner dependent on photosensitizer dose and light energy. The IC50 values of TONS501Na against EMT6 cells were 8.2 and 2.2 µg/ml at a laser power of 6 and 13 J/cm2, respectively (6). In the present study, it was determined that TONS504-mediated PDT-induced EMT6 cell death in a dose-dependent manner. The IC50 values of TONS504 against EMT6 cells were 5.9 and 1.9 µg/ml at light doses of 5 and 10 J/cm2, respectively. Although the experimental conditions were slightly different between the two studies, the IC50 of TONS504 was similar to that of TONS501Na. In addition, dark cytotoxicity was observed with TONS501Na in our previous study (6); however, this was not observed with TONS504 in the present study. Therefore, TONS504 is a photosensitizer more suitable for tumor therapy than TONS501Na.

Fig. 5 depicted that apoptotic cell death induced by TONS504-mediated PDT increased in a time-dependent manner and was initiated at 1–3 h after PDT. The cells treated with 10 µg/ml TONS504 and a light dose of 5 J/cm2 were mainly necrotic (Fig. 6C). Furthermore, the cells treated with 30 µg/ml TONS504 and a light dose of 5 J/cm2 underwent either late apoptosis or early-stage necrosis (Fig. 7C). The percentages of ROS(+) cells and apoptotic cells in the group subjected to TONS504-mediated PDT increased in a light-energy-dependent manner. When the cells were treated with 10 or 30 µg/ml TONS504 and with a light dose of 10 J/cm2, the percentage of ROS(+) cells treated with 30 µg/ml TONS504 (56.1%) was lower than that of cells treated with 10 µg/ml TONS504 (70.1%). The results demonstrated that PDT with a high dose of TONS504 may result in a rapid decrease in the number of ROS(+) cells. This is due to the notable decrease in cell viability and the rapid induction of apoptosis by TONS504 at a concentration of 30 µg/ml. The results also indicated that TONS504-mediated PDT may induce apoptosis, but not ROS-induced damage. It was considered that the differences in cell death induced by TONS504-PDT may be associated with the intracellular accumulation of TONS504, mainly in the lysosomes.

We hypothesized that apoptosis induced by TONS504-mediated PDT may be dependent on lysosomal damage. A previous report indicated that apoptosis induced by ATX-S10-mediated PDT was dependent on lysosomal damage (13). In addition, ATX-S10 was localized to the mitochondria and lysosomes. It has been hypothesized that ATX-S10-mediated PDT initiates an apoptotic response through direct damage to lysosomes. Furthermore, it regulates cell death through photodamage to B-cell lymphoma-2 (Bcl-2) by inducing direct and indirect damage to the mitochondria (13). Talaporfin sodium (NPe6) is also localized in lysosomes. It was reported that following treatment of murine hepatoma 1c1c7 cells with NPe6-PDT, there was a delayed apoptotic response, which was marked by rapid destruction of lysosomes, BH3-interacting domain death agonist (Bid) cleavage to generate the proapoptotic Bcl-2 family member t-Bid, and activation of caspase-3 and −9. Bid activation decreased mitochondrial membrane potential and cytochrome-c release (14,15). Additionally, photodamaged lysosomes triggered the mitochondrial apoptotic pathway by releasing proteases that activate Bid (14). It was considered that Bid may be activated by high-dose PDT, but not by low-dose PDT. Depending on the extent of photodamage, either apoptosis or necrosis was considered to be initiated; therefore, in the present study, it was considered that apoptosis induced by TONS504-mediated PDT may be dependent on the extent of lysosomal damage, as well as direct and indirect mitochondrial damage. However, these results are only based on in vitro studies, and further in vivo studies are necessary.

In conclusion, TONS504-mediated PDT induced the death of mouse mammary tumor cells in a manner dependent on the TONS504 dose and light energy. In addition, TONS504 did not induce dark cytotoxicity. Therefore, TONS504 could be an ideal photosensitizer for PDT against tumors. However, future studies are warranted to evaluate the in vivo pharmacokinetics, tissue distribution and photodynamic effects of TONS504 in a mouse model of EMT6 mammary tumors.

Acknowledgements

The authors would like to thank Mr Shohei Shimonishi (Essen BioScience, Inc., Tokyo, Japan) for providing technical assistance with the experiments.

Funding

The present study was partly funded by Saisei Mirai Clinic (Osaka, Japan).

Availability of data and materials

All data generated and analyzed during the present study are included in this published article.

Authors' contributions

TO, IS and YU conceived, designed, and performed the experiments and wrote the paper. MY, YM, KA, TT, NI, TI and YO interpreted the data and were involved in drafting the manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

George BP and Abrahamse H: A review on novel breast cancer therapies: Photodynamic therapy and plant derived agent induced cell death mechanisms. Anticancer Agents Med Chem. 16:793–801. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI

3 

Banerjee SM, MacRobert AJ, Mosse CA, Periera B, Bown SG and Keshtgar MRS: Photodynamic therapy: Inception to application in breast cancer. Breast. 31:105–113. 2017. View Article : Google Scholar : PubMed/NCBI

4 

Bacellar IO, Tsubone TM, Pavani C and Baptista MS: Photodynamic efficiency: From molecular photochemistry to cell death. Int J Mol Sci. 16:20523–20559. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Triesscheijn M, Baas P, Schellens JH and Stewart FA: Photodynamic therapy in oncology. Oncologist. 11:1034–1044. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Osaki T, Sakata I, Uto Y, Azuma K, Murahata Y, Tsuka T, Itoh N, Imagawa T and Okamoto Y: Photodynamic therapy mediated by a novel chlorin derivative, TONS 501-Na, in EMT6 cells. Anticancer Res. 37:1723–1728. 2017. View Article : Google Scholar : PubMed/NCBI

7 

Takahashi H, Nakajima S, Asano R, Nakae Y, Sakata I and Iizuka H: Photodynamic therapy using a novel photosensitizer, TONS501, is similarly effective to ALA and EC036 photodynamic therapy on DMBA-and TPA-induced mouse skin papilloma. J Dermatol Sci. 66:221–224. 2012. View Article : Google Scholar : PubMed/NCBI

8 

Sakata I: Chlorin derivatives. Japan patent JP5651426. B2:2015-01-14.

9 

Latief MA, Chikama T, Shibasaki M, Sasaki T, Ko JA, Kiuchi Y, Sakaguchi T and Obana A: Antimicrobial action from a novel porphyrin derivative in photodynamic antimicrobial chemotherapy in vitro. Lasers Med Sci. 30:383–387. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Latief MA, Chikama T, Ko JA, Kiuchi Y, Sakaguchi T and Obana A: Inactivation of acyclovir-sensitive and -resistant strains of herpes simplex virus type 1 in vitro by photodynamic antimicrobial chemotherapy. Mol Vis. 21:532–537. 2015.PubMed/NCBI

11 

Berlanda J, Kiesslich T, Engelhardt V, Krammer B and Plaetzer K: Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. J Photochem Photobiol B. 100:173–180. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Kou L, Sun J, Zhai y and He Z: The endocytosis and intracellular fate of nanomedicines: Implication for rational design. AJPS. 8:1–10. 2013.

13 

Ichinose S, Usuda J, Hirata T, Inoue T, Ohtani K, Maehara S, Kubota M, Imai K, Tsunoda Y, Kuroiwa Y, et al: Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int J Oncol. 29:349–355. 2006.PubMed/NCBI

14 

Reiners JJ Jr, Caruso JA, Mathieu P, Chelladurai B, Yin XM and Kessel D: Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 9:934–944. 2002. View Article : Google Scholar : PubMed/NCBI

15 

Ribeiro JN, da Silva AR and Jorge RA: Involvement of mitochondria in apoptosis of cancer cells induced by photodynamic therapy. J Bras Patol Med Lab. 40:383–390. 2004. View Article : Google Scholar

Related Articles

Journal Cover

August-2018
Volume 16 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Osaki T, Sakata I, Uto Y, Yamashita M, Murahata Y, Azuma K, Tsuka T, Ito N, Imagawa T, Okamoto Y, Okamoto Y, et al: Effects of TONS504‑photodynamic therapy on mouse mammary tumor cells. Oncol Lett 16: 2078-2084, 2018
APA
Osaki, T., Sakata, I., Uto, Y., Yamashita, M., Murahata, Y., Azuma, K. ... Okamoto, Y. (2018). Effects of TONS504‑photodynamic therapy on mouse mammary tumor cells. Oncology Letters, 16, 2078-2084. https://doi.org/10.3892/ol.2018.8887
MLA
Osaki, T., Sakata, I., Uto, Y., Yamashita, M., Murahata, Y., Azuma, K., Tsuka, T., Ito, N., Imagawa, T., Okamoto, Y."Effects of TONS504‑photodynamic therapy on mouse mammary tumor cells". Oncology Letters 16.2 (2018): 2078-2084.
Chicago
Osaki, T., Sakata, I., Uto, Y., Yamashita, M., Murahata, Y., Azuma, K., Tsuka, T., Ito, N., Imagawa, T., Okamoto, Y."Effects of TONS504‑photodynamic therapy on mouse mammary tumor cells". Oncology Letters 16, no. 2 (2018): 2078-2084. https://doi.org/10.3892/ol.2018.8887